AFCM
DXCM icon

Alta Fox Capital Management’s DexCom DXCM Stock Holding History

Alta Fox Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-379,100
Closed -$25.5M – 16
2025
Q3 		$25.5M Buy
379,100
+131,200
+53% +$10.4M 5.69% 5
2025
Q2 		$21.6M Buy
+247,900
New +$19.4M 5.88% 4

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Alta Fox Capital Management's DXCM Position: Q4 2025 in Review

Alta Fox Capital Management sold out of DexCom (DXCM) in Q4 2025, closing a stake of 379,100 shares — an estimated $25.5M sold.

Alta Fox Capital Management first reported a position in DXCM in Q2 2025 and held it in 2 quarters. The position peaked at $25.5M in Q3 2025. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Alta Fox Capital Management reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Alta Fox Capital Management sold 379,100 DexCom shares in Q4 2025, an estimated $25.5M.
  • Alta Fox Capital Management first reported a position in DexCom in Q2 2025 and held it in 2 quarters.
  • Alta Fox Capital Management's DexCom position peaked at $25.5M in Q3 2025.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Alta Fox Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.